Projekt · Dnr 2021-01834 · Källa: Vinnova
Hur formar kalcium signalering hjärnans funktion under tidig neurogenes?
- Koordinator
- Karolinska Institutet
- Projekttid
- 2021-05-01 till 2023-04-30 (avslutat)
- Beviljat bidrag
- 1 918 560 SEK
- Diarienummer
- 2021-01834
Beskrivning
The overall aim of this project was to understand how Ca2+ transients and their signalling pathways affect early neurogenesis and underlie severe brain disorders. To this end, patient and control induced pluripotent stem cell derived models of early neurogenesis where used to: 1. Identify the time course and type of Ca2+ fluxes present in iPSCs and over early neural differentiation. 2. The role of cell-adhesion molecules in regulating Ca2+ fluxes at different stages of neurogenesis and their correlation with cell-fate. 3. The contribution of the above mechanisms to brain disorders. The results obtained in this project increased our understanding of how Ca2+ signaling contributes to the maintenance and derivation of human iPSCs for disease modeling, how Ca2+ signaling affects early human brain development and how their defects underlie developmental brain disorders. It further aided in the standardisation of hiPSC cultures, and providing researchers with key tools for the application of hiPSCs in neuropharmacological studies, brain disease modelling and stem-cell therapies.
Hittar Vinnova inte sidan? Sök på diarienumret hos Vinnova.
Liknande
-
Kroppstillhörighetens roll i prediktiva rörelser
Karolinska Institutet · 2020-01-01 · 559 580 SEK · Projekt
When we move, we trust that we automatically know which parts of the world make up our body and which parts do not. When this project is finished, it will provide exciting new information about how the sense of ownership over our body affects our ability to perform movements. This will increase our …
-
Förberedelse av EU-ansökan: Innovation inom cellterapi för neurodegenerativa sjukdomar
Oscillution AB · 2025-06-14 · 117 460 SEK · Projekt
Projektet resulterade i förberedelse och inlämning av en EU-ansökan inom cellterapi för neurodegenerativa sjukdomar. Oscillution AB deltog som partner och bidrog med utveckling av en human in vitro-modell för säkerhetstestning. Ansökan lämnades in inom Horizon Europe-programmet och stärker framtida …
-
Neupron to stimulate therapeutic neurogenesis
NeuroNova AB · 2005-03-10 · 500 000 SEK · Projekt
-
LC-MS System
Göteborgs universitet · 2025-06-04 · sista anbudsdag 2025-08-10 · 13 500 000 SEK · Upphandling
The research group of Neurochemical pathophysiology and diagnostics at the Institute of Neuroscience and Physiology at the University of Gothenburg conducts research in biomarkers of neurodegenerative diseases, including biomarker discovery by clinical proteomics, development of targeted biomarker a…
-
LC-MS System
Göteborgs universitet · 2025-09-09 · 11 639 922 SEK · Tilldelning
The research group of Neurochemical pathophysiology and diagnostics at the Institute of Neuroscience and Physiology at the University of Gothenburg conducts research in biomarkers of neurodegenerative diseases, including biomarker discovery by clinical proteomics, development of targeted biomarker a…